LATE-BREAKING ABSTRACT: Safety and tolerability of N-acetylcysteine (NAC) with pirfenidone in idiopathic pulmonary fibrosis (IPF): PANORAMA
Juergen Behr (Munich, Germany), Jrgen Behr, Elisabeth Bendstrup, Bruno Crestani, Andreas Gnther, Horst Olschewski, Magnus Skld, Athol Wells, Wim Wuyts, Dirk Koschel, Michael Kreuter, Benoit Wallaert, Helen Tang, Jrgen Beck, Carlo Albera
Source: International Congress 2015 – Latest developments in clinical studies in acute and chronic lung diseases
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Juergen Behr (Munich, Germany), Jrgen Behr, Elisabeth Bendstrup, Bruno Crestani, Andreas Gnther, Horst Olschewski, Magnus Skld, Athol Wells, Wim Wuyts, Dirk Koschel, Michael Kreuter, Benoit Wallaert, Helen Tang, Jrgen Beck, Carlo Albera. LATE-BREAKING ABSTRACT: Safety and tolerability of N-acetylcysteine (NAC) with pirfenidone in idiopathic pulmonary fibrosis (IPF): PANORAMA. Eur Respir J 2015; 46: Suppl. 59, 3477
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: